2/5
08:23 pm
mrk
????????:2032????66?5000??????????????(CAGR)8.1%??? [CNET News]
Low
Report
????????:2032????66?5000??????????????(CAGR)8.1%??? [CNET News]
2/5
01:28 pm
mrk
Merck veteran Perlmutter-led Eikon ?Therapeutics valued at $860 million in Nasdaq debut [Yahoo! Finance Canada]
Low
Report
Merck veteran Perlmutter-led Eikon ?Therapeutics valued at $860 million in Nasdaq debut [Yahoo! Finance Canada]
2/5
07:46 am
mrk
Merck Announces Health Canada Approval of ENFLONSIA® for the prevention of RSV in newborns and infants [Globe and Mail, The (Toronto, Canada)]
Low
Report
Merck Announces Health Canada Approval of ENFLONSIA® for the prevention of RSV in newborns and infants [Globe and Mail, The (Toronto, Canada)]
2/4
09:01 pm
mrk
Perlmutter-backed Eikon Therapeutics raises $381.2 million in IPO [Yahoo! Finance]
Low
Report
Perlmutter-backed Eikon Therapeutics raises $381.2 million in IPO [Yahoo! Finance]
2/4
03:47 pm
mrk
Jim Cramer on Merck & Co.: “This Is One of My Favorite Pharmaceutical Stocks” [Yahoo! Finance]
Low
Report
Jim Cramer on Merck & Co.: “This Is One of My Favorite Pharmaceutical Stocks” [Yahoo! Finance]
2/4
02:52 pm
mrk
Moderna CEO hails breakthrough mRNA cancer vaccine that halves melanoma recurrence risk with Keytruda [FOX Business Network]
Low
Report
Moderna CEO hails breakthrough mRNA cancer vaccine that halves melanoma recurrence risk with Keytruda [FOX Business Network]
2/4
01:32 pm
mrk
Where is Merck & Co. (MRK) Headed According to Wall Street? [Yahoo! Finance]
Low
Report
Where is Merck & Co. (MRK) Headed According to Wall Street? [Yahoo! Finance]
2/4
01:16 pm
mrk
Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at Citigroup Inc. from $115.00 to $120.00. They now have a "neutral" rating on the stock.
Low
Report
Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at Citigroup Inc. from $115.00 to $120.00. They now have a "neutral" rating on the stock.
2/4
11:36 am
mrk
Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at Cantor Fitzgerald from $116.00 to $120.00. They now have a "neutral" rating on the stock.
Low
Report
Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at Cantor Fitzgerald from $116.00 to $120.00. They now have a "neutral" rating on the stock.
2/4
10:42 am
mrk
Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at Wells Fargo & Company from $125.00 to $135.00. They now have an "overweight" rating on the stock.
Low
Report
Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at Wells Fargo & Company from $125.00 to $135.00. They now have an "overweight" rating on the stock.
2/4
01:21 am
mrk
Merck & Co., Inc. Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Merck & Co., Inc. Q4 Earnings Call Highlights [Yahoo! Finance]
2/3
11:27 pm
mrk
Merck Reports Earnings Tuesday Morning After Gaining 13% Over the Past Year [Yahoo! Finance]
Low
Report
Merck Reports Earnings Tuesday Morning After Gaining 13% Over the Past Year [Yahoo! Finance]
2/3
02:36 pm
mrk
Are Wall Street Analysts Bullish on Moderna Stock? [Yahoo! Finance]
Low
Report
Are Wall Street Analysts Bullish on Moderna Stock? [Yahoo! Finance]
2/3
01:35 pm
mrk
Merck & Co., Inc. (MRK) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Merck & Co., Inc. (MRK) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/3
12:40 pm
mrk
Merck 2026 Outlook Misses as Gardasil Sales Drop 35% [Yahoo! Finance]
Low
Report
Merck 2026 Outlook Misses as Gardasil Sales Drop 35% [Yahoo! Finance]
2/3
12:23 pm
mrk
Merck (MRK) Reports Q4 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
Low
Report
Merck (MRK) Reports Q4 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
2/3
11:33 am
mrk
Merck (MRK) Is Up 5.6% After Cautious 2026 Outlook And Ongoing Oncology Investment Plans – What's Changed [Yahoo! Finance]
Low
Report
Merck (MRK) Is Up 5.6% After Cautious 2026 Outlook And Ongoing Oncology Investment Plans – What's Changed [Yahoo! Finance]
2/3
11:22 am
mrk
Here's Why Gilead Sciences Stock Surged 21% in a Month [Yahoo! Finance]
Low
Report
Here's Why Gilead Sciences Stock Surged 21% in a Month [Yahoo! Finance]
2/3
11:00 am
mrk
Merck (MRK) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Merck (MRK) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
2/3
08:31 am
mrk
Merck and Pfizer decline vs the broader market as results released [Yahoo! Finance]
Low
Report
Merck and Pfizer decline vs the broader market as results released [Yahoo! Finance]
2/3
08:25 am
mrk
Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms [MSNBC.com]
Low
Report
Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms [MSNBC.com]
2/3
07:55 am
mrk
Merck's (NYSE:MRK) Q4 CY2025 Sales Beat Estimates [Yahoo! Finance]
Low
Report
Merck's (NYSE:MRK) Q4 CY2025 Sales Beat Estimates [Yahoo! Finance]
2/3
07:31 am
mrk
Jim Cramer on Merck & Co.: “I Think It Can Spread Out the Wealth” [Yahoo! Finance]
Low
Report
Jim Cramer on Merck & Co.: “I Think It Can Spread Out the Wealth” [Yahoo! Finance]
2/3
07:23 am
mrk
China NMPA Approves Promega MSI Detection Kit as Companion Diagnostic for KEYTRUDA® [Yahoo! Finance]
Low
Report
China NMPA Approves Promega MSI Detection Kit as Companion Diagnostic for KEYTRUDA® [Yahoo! Finance]
2/3
07:00 am
mrk
Earnings Snapshot: Merck tops Q4, issues weaker-than-expected FY profit and sales outlook [Seeking Alpha]
Medium
Report
Earnings Snapshot: Merck tops Q4, issues weaker-than-expected FY profit and sales outlook [Seeking Alpha]